Back to search

Article

N,N-Dimethylacetamide Targets Neuroinflammation in Alzheimer’s Disease in In-vitro and Ex-vivo Models

2022-12-20

Abstract excerpt

Alzheimer’s disease (AD) is a chronic degenerative brain disorder with no clear pathogenesis or effective cure, accounting for 60–80% cases of dementia. In recent years, the importance of neuroinflammation in the pathogenesis of AD and other neurodegenerative disorders has come into focus. Previously, we made the serendipitous discovery that the widely used drug excipient N,N-dimethylacetamide (DMA) attenuates end...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24bc45fd-246a-573a-831f-afcb7378eb0c
DOI
10.21203/rs.3.rs-2363746/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N,N-Dimethylacetamide Targets Neuroinflammation in Alzheimer’s Disease in In-vitro and Ex-vivo ModelsDOI 10.21203/rs.3.rs-2363746/v1
Select a neighboring publication to make it the new centre.